Study reveals potential to reverse lung fibrosis using the body’s own healing technique

5:00 AM

Author | Kelly Malcom

A CT scan of healthy lungs
A CT scan of healthy lungs

The most common type of lung fibrosis — scarring of the lungs -- is idiopathic, meaning of unknown cause. 

Researchers are urgently trying to find ways to prevent or slow idiopathic pulmonary fibrosis (IPF) and related lung conditions, which can cause worsening shortness of breath, dry cough, and extreme fatigue. Average survival following diagnosis of IPF is just three to five years, and the disease has no cure.

A recent U-M study from a team led by Sean Fortier, M.D. and Marc Peters-Golden, M.D. of the Division of Pulmonary and Critical Care Medicine at U-M Medical School uncovers a pathway used during normal wound healing that has the potential to reverse IPF.

Lung scarring

Using a mouse model, they simulated IPF by administering bleomycin, a chemotherapy agent that causes cell injury and confirmed that the resulting lung scarring resolved itself over the span of about six weeks. 

Because of this, “studying fibrosis is kind of tough,” said Fortier.  “If we’re going to give experimental drugs to try and resolve fibrosis, we have to do it before it resolves on its own. 

Otherwise, we will not be able to tell if the resolution was the action of the drug or natural repair mechanisms of the body.”

However, he said, “there’s actually a lot to learn about how the mouse gets better on its own. If we can learn the molecular mechanisms by which this occurs, we may uncover new targets for IPF.”

Fibroblast cells

The process by which lung injury either leads to healing or fibrosis relies in part on what happens to a cell called a fibroblast, which forms connective tissue. 

During injury or illness, fibroblasts are activated, becoming myofibroblasts that form scar tissue by secreting collagen. When the job is done, these fibroblasts must be deactivated, or de-differentiated, to go back to their quiet state or undergo programmed cell death and be cleared. 

“This is the major distinction between normal wound healing and fibrosis – the persistence of activated myofibroblasts,” explained Fortier. That deactivation is controlled by molecular brakes. The study examined one of these brakes, called MKP1 – which the team found was expressed at lower levels in fibroblasts from patients with IPF.

By genetically eliminating MKP1 in fibroblasts of mice after establishing lung injury, the team saw that fibrosis continued uncontrolled.

“Instead of at day 63, seeing that nice resolution, you still see fibrosis,” said Fortier. 

“We argued by contradiction: when you knock out this brake, fibrosis that would otherwise naturally disappear, persists and therefore MKP1 is necessary for spontaneous resolution of fibrosis.”

CRISPR techniques

They performed several additional studies using CRISPR techniques to demonstrate how MKP1 applies the brakes, mainly by deactivating the enzyme p38α, which is implicated in a cell’s reaction to stress.

Furthermore, they demonstrated that neither of the two current FDA approved drugs for lung fibrosis, pirfenidone and nintedanib, are able to turn off myofibroblasts.

“That’s totally in keeping with the fact that they do slow the progression, but they don’t halt or reverse disease,” said Fortier.

Fortier hopes the discovery that this pathway reverses fibrosis leads to exploration of additional brakes on fibrosis. 

“So much work on fibrosis has focused on how we can prevent it, but when a patient presents to my clinic with a dry cough, shortness of breath, and low oxygen as a result of underlying IPF, the scarring is already present. Of course, we’d love a way to prevent the scarring from getting worse, but the Holy Grail is to reverse it.”

Additional authors: Natalie Walker, Loka R. Penke, Jared Baas, Qinxue Shen, Jennifer Speth, Steven K. Huang, Rachel L. Zemans, and Anton M. Bennett

Citation: “MAP kinase phosphatase-1 inhibition of p38α within lung myofibroblasts is essential for spontaneous fibrosis resolution,” Journal of Clinical Investigation. DOI: 10.1172/JCI172826


More Articles About:

Pulmonary Fibrosis Basic Science and Laboratory Research Pulmonary Rehabilitation Internal Medicine Critical Care
Health Lab word mark overlaying blue cells

Health Lab

Explore thousands of health news & research stories by visiting the Health Lab homepage for more.

Media Contact

University Hospital at U-M Health in the spring with flowering trees in foreground and Survival Flight helicopter visible

Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

In This Story

portrait of Sean Fortier

Sean Fortier, MD

Assistant Professor

Related

Health Lab

Blocking the Molecular Source of Idiopathic Pulmonary Fibrosis

Successfully tested in mice, targeted drug and gene therapies might one day benefit patients with a deadly lung disease, new U-M research finds.

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe

Featured News & Stories

Alarm clock sitting on a white dinner plate with blue and yellow flowers on the rim and a fork and knife positioned on either side of the plate.
Health Lab

Intermittent fasting can reverse diabetes in mice, study finds

Study shows intermittent fasting and meal timing can help reverse type 2 diabetes by resting pancreatic beta cells
MRNA splicing transcription on a blue background
Health Lab

Study reveals why a rare mutation behind Dravet syndrome is so deadly

Rare mutation behind Dravet syndrome found to be deadly.
Two women and a man sing on a stage with the backdrop of an ocean. The man is playing the guitar.
Health Lab

Lung transplant recipient donates lungs to science

After being diagnosed with idiopathic pulmonary fibrosis, woman needed a lung transplant. She chose the University of Michigan Health Transplant Center for their excellent care and ability to donate her lungs to science.
Blue round cells in three pictures showing how they change under stress.
Health Lab

Timing is of the essence for RNA during stress

Key determiners of which RNA can be read to make proteins is time. Previous thinking was that a cell under threat would quickly make these RNAs in the nucleus and immediately push them into the cytoplasm.
1906 psychopathic hospital
News Release

Exploring the mind’s mysteries: 130 years of mental health care & innovation at U-M

When it opened in 1906 on Catherine Street near the University of Michigan’s main hospitals, the stately brick State Psychopathic Hospital meant something new in the world of mental health.
Perforin increases endosomal-mitochondrial contact sites in tumor cells. Left is without perforin; right has perforin.
Health Lab

Immune system protein is a cancer killer on its own, new study shows

New study finds perforin can kill cancer tumor cells even when major granzymes were missing.